Novel pharmaceutical formulations and their use in the treatment of periodontal disease
a technology of pharmaceutical formulations and periodontal disease, applied in the direction of pharmaceutical non-active ingredients, cyclic peptide ingredients, depsipeptide ingredients, etc., can solve the problems of no treatment that addresses, halt or reverse the tissue and bone destructive process, tooth loss, etc., and achieve the effect of improving long-term stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
[0253]To a 5% suspension of cyclosporin in glycerol were added under mechanical agitation (rotor-stator mixer, Ultra Turrax T25) 1% of TPGS, 0.01% chlorhexidine, 7% gelatin, and 10% hydroxypropyl cellulose. The resulting pre-dispersion was then homogenised using 3 cycles at 500 bar and 10 cycles at 1,500 bar in a Gaulin Micron Lab40 high pressure homogeniser at room temperature. Particle size analysis showed a D50% of 1.8 μM, a D75% of 4.6 μM and a D95% of 5.6 μM.
example 2
[0254]The same experimental protocol as in example 1 but using 20 high pressure homogenisation cycles gave cyclosporin nanoparticles with a D95% of 960 nM.
example 3
[0255]The experimental protocol of example 2 but substituting Polyoxamer 407 for TPGS and 20 high pressure homogenisation cycles gave cyclosporin nanoparticles with a D50% of 890 nM and a D95% of 1.7 μM.
[0256]General Nanomilling Procedure (Pilot Scale)
[0257]The indicated amount of purified water was weighed into a glass beaker of suitable size. Afterwards the listed amounts of surfactant and stabilising polymer were added under magnetic stirring until the components fully dissolved. The described amount of cyclosporin was slowly added under stirring to give an almost homogenous suspension. The suspension was transferred into the milling system (e.g. Netzsch, DeltaVita). The milling system has been previously loaded with milling beads with approx. 0.2 mm diameter. The milling is performed under controlled temperature conditions (<40° C.) over a suitable time (2-5 h) using an appropriate milling speed (2000-3000 rpm).
[0258]Characterisation
[0259]The isolated nano-suspensions have been ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
| particle size | aaaaa | aaaaa |
| size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 



